Characteristics and treatment patterns of patients with Obstructive Sleep Apnea (OSA) initiating Positive Airway Pressure (PAP) therapy

Study identification

• EU PAS number:
  EUPAS49842
• Study ID:
  49843
• Official title and acronym:
  Characteristics and treatment patterns of patients with Obstructive Sleep Apnea (OSA) initiating Positive Airway Pressure (PAP) therapy
• DARWIN EU® study:
  No
• Study countries:
  United States
• Study description:
  There is a lack of comprehensive assessment about the processes involved for OSA patients, from sleep test, diagnosis, utilization of PAP, and their overall related health care service utilization. This study aims to examine OSA patients’ adherence to PAP treatments, along with assessing their health care resource utilization (HCRU) and associated costs. Additionally, the study aims to explore the patient journey through different stages from the initial sleep test to being prescribed PAP treatment.
• Study status:
  Planned

Research institutions and networks

Institutions

HealthCore

Study timelines

Date when funding contract was signed

Planned:08/08/2022

Actual:08/08/2022

Study start date

Planned:12/01/2022

Date of final study report

Planned:28/07/2023

Sources of funding

Pharmaceutical company and other private sector 

More details on funding

Eli Lilly

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable